Mupirocin FDA Link Generic

A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.

Also Known As:

Bactroban; BRL-4910A; Mupirocin Calcium; Mupirocin, 14C-Labeled; Mupirocin, Calcium Salt (2:1); Mupirocin, Calcium Salt (2:1), Dihydrate; Mupirocin, Lithium Salt; Mupirocin, Sodium Salt; Pseudomonic Acid A; 14C-Labeled Mupirocin; BRL 4910A; BRL4910A; Mupirocin, 14C Labeled; Pseudomonic Acid; Nonanoic acid, 9- ((3- methyl- 1- oxo- 4- (tetrahydro- 3,4- dihydroxy- 5- ((3- (2- hydroxy- 1- methylpropyl)oxiranyl)methyl)- 2H- pyran- 2- yl)- 2- butenyl)oxy)- , (2S- (2alpha(E),3beta,4beta,5alpha(2R*,3R*(1R*,2R*))))-

Pharmalogical Action Categories:

Anti-Bacterial Agents
Protein Synthesis Inhibitors

Organic Chemicals: 133
- Ethers: 242
  - Cyclic Ethers: 12
    - Epoxy Compounds: 689
      - Mupirocin: 693
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Mupirocin: 693
Lipids: 114793
- Fatty Acids: 27405
  - Mupirocin: 693

Istar Dolapçi Selected Research

Istar Dolapçi Research Topics

Disease

Drug/Important Bio-Agent (IBA)